© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
May 12, 2021
Bayer has submitted a New Drug Application for the mineralocorticoid receptor antagonist.
May 11, 2021
The smart pen cap system is associated with real-time hypoglycemia alerts and insulin dose recommendations.
May 08, 2021
Research at ARVO 2021 highlighted a gamut of interplaying diabetes and vision loss risk factors, and even treatments for both. But experts depict a referral and care process that lacks whole diabetes care.
May 06, 2021
A new study finds the top 10 future research priorities into diabetes and pregnancy.
The diabetes and ophthalmology overlap is significant and growing in the US. A Cleveland Clinic expert discusses crossover research and care.
May 05, 2021
A discussion with an investigator on how the SGLT-2 inhibitor may help affected patients.
From cross-specialty collaboration to machine learning and public messaging, an expert details strategies for better eye exam and follow-up.
New data show dasiglucagon a reliable and rapid treatment in restoring plasma glucose levels.
A discussion on the uncovered benefits in risk reduction observed in patients with severe NDPR.
CDC data suggest ophthalmic patients are significantly more likely to present with a heart disease-driving condition or habit. How could preventive care improve?